Earlier this week, the Centers for Medicare & Medicaid Services (CMS) released guidance to states and manufacturers through State Release #184 and Manufacturer Release #107. These releases provide information pertaining to the use of CMS’s drug product data to determine drug coverage by states under the Medicaid Drug Rebate (MDR) Program as well as other operational guidance specific to the MDR Program. These releases are now available for download at the following link:https://www.medicaid.gov/
aportes a la gestión necesaria para la sustentabilidad de la SALUD PÚBLICA como figura esencial de los servicios sociales básicos para la sociedad humana, para la familia y para la persona como individuo que participa de la vida ciudadana.
jueves, 2 de noviembre de 2017
Program Releases | Medicaid.gov
Program Releases | Medicaid.gov

Earlier this week, the Centers for Medicare & Medicaid Services (CMS) released guidance to states and manufacturers through State Release #184 and Manufacturer Release #107. These releases provide information pertaining to the use of CMS’s drug product data to determine drug coverage by states under the Medicaid Drug Rebate (MDR) Program as well as other operational guidance specific to the MDR Program. These releases are now available for download at the following link:https://www.medicaid.gov/ medicaid/prescription-drugs/ program-releases/index.html
Earlier this week, the Centers for Medicare & Medicaid Services (CMS) released guidance to states and manufacturers through State Release #184 and Manufacturer Release #107. These releases provide information pertaining to the use of CMS’s drug product data to determine drug coverage by states under the Medicaid Drug Rebate (MDR) Program as well as other operational guidance specific to the MDR Program. These releases are now available for download at the following link:https://www.medicaid.gov/
No hay comentarios:
Publicar un comentario